GLP-1 Agonists Associated with Doubled Risk of Neovascular AMD, Study Finds
Blockbuster meds, blockbuster risks? Trending GLP-1s (like Ozempic) are now raising red flags for nAMD. A new population-based cohort study…
Blockbuster meds, blockbuster risks? Trending GLP-1s (like Ozempic) are now raising red flags for nAMD. A new population-based cohort study…